Rights and permissions
About this article
Cite this article
Nilotinib effective in imatinib-resistant/intolerant CML. Inpharma Wkly. 1575, 7–8 (2007). https://doi.org/10.2165/00128413-200715750-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200715750-00018